Researchers are investigating whether the drug could be used in mainstream medicine—with and without its hallucinatory ...
LSD usage is on the rise among U.S. adults – especially young adults with depression. And the trend mirrors growing research into the psychedelic drug's ability to treat mental health disorders like ...
Australian R&D company MindBio Therapeutics conducted a first-ever Phase 2a take-home microdosing trial to treat depression.. 53% of patients went into complete depression remission after 8 weeks of ...
LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...
A rigorous new study finds that a single dose of LSD can ease a person's anxiety for months. NPR's Jon Hamilton reports that the study shows how research on psychedelics is entering the mainstream.
A single dose of an LSD formulation designed to treat generalized anxiety disorder (GAD) can provide lasting relief within weeks, according to the biopharmaceutical company’s findings. MindMed, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results